SYS6010

· CSPC Megalith Biopharmaceutical Co.,Ltd.

Drug timelines are a Plus or Pro feature.

10 regulatory and trial events tracked for SYS6010, covering 2025-03-19 to 2026-03-04. Get the full timeline:

Most recent: Clinical Trial Update: SYS6010 Versus Docetaxel for Previously Treated EGFR Wild-type NSCLC: Phase Ⅲ [Phase 3]